Intrauterine Growth Restriction clinical trials

Explore recruiting intrauterine growth restriction clinical trials.

Recruiting intrauterine growth restriction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intrauterine Growth Restriction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of certolizumab in women with unexplained recurrent implantation failure: a double-blind randomized controlled trial (CERTIFY)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Statin Intervention for Severe Early-Onset Placental Insufficiency: A Randomized Controlled Trial Assessing daily Administration as a Treatment Strategy (STATIN-PRE trial)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cook´s balloon versus dinoprostone for Labor Induction of term pregnancies with fetal GROWth restriction (COLIGROW study)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Contribution of Contrast-Enhanced Ultrasound (CES) in the fetal-placental circulation study: EVUPACUS

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Reproductive outcomes with letrozole co-treatment during ovarian stimulation in women with endometriosis undergoing IVF/ICSI: a randomised, multicentre, parallel group pragmatic trial

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Intrauterine Growth Restriction trials by city

Intrauterine Growth Restriction in Toronto Intrauterine Growth Restriction in Vancouver Intrauterine Growth Restriction in Montreal Intrauterine Growth Restriction in Calgary Intrauterine Growth Restriction in Edmonton Intrauterine Growth Restriction in Ottawa Intrauterine Growth Restriction in Winnipeg Intrauterine Growth Restriction in Quebec City Intrauterine Growth Restriction in Hamilton Intrauterine Growth Restriction in Kitchener Intrauterine Growth Restriction in London Intrauterine Growth Restriction in Halifax Intrauterine Growth Restriction in New York Intrauterine Growth Restriction in Los Angeles Intrauterine Growth Restriction in Chicago Intrauterine Growth Restriction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease